1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Moderate Psoriasis Global Clinical Trials Review, H2, 2014

Moderate Psoriasis Global Clinical Trials Review, H2, 2014

  • October 2014
  • -
  • Global Data
  • -
  • 115 pages

Moderate Psoriasis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Moderate Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Moderate Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Moderate Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Moderate Psoriasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Moderate Psoriasis Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Moderate Psoriasis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Moderate Psoriasis to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Moderate Psoriasis to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Moderate Psoriasis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Moderate Psoriasis Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
AbbVie Inc. 34
Clinical Trial Overview of AbbVie Inc. 34
Amgen Inc. 37
Clinical Trial Overview of Amgen Inc. 37
Johnson and Johnson 39
Clinical Trial Overview of Johnson and Johnson 39
Pfizer Inc. 41
Clinical Trial Overview of Pfizer Inc. 41
Merck and Co., Inc. 43
Clinical Trial Overview of Merck and Co., Inc. 43
F. Hoffmann-La Roche Ltd. 45
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 45
Novartis AG 46
Clinical Trial Overview of Novartis AG 46
Innovaderm Research Inc. 47
Clinical Trial Overview of Innovaderm Research Inc. 47
E. Merck KG 48
Clinical Trial Overview of E. Merck KG 48
Eli Lilly and Company 49
Clinical Trial Overview of Eli Lilly and Company 49
Clinical Trial Overview of Top Institutes / Government 50
Rutgers, The State University of New Jersey 50
Clinical Trial Overview of Rutgers, The State University of New Jersey 50
Tufts Medical Center 51
Clinical Trial Overview of Tufts Medical Center 51
Dresden University of Technology 52
Clinical Trial Overview of Dresden University of Technology 52
University of California, San Francisco 53
Clinical Trial Overview of University of California, San Francisco 53
Academic Medical Center 54
Clinical Trial Overview of Academic Medical Center 54
Wake Forest University 55
Clinical Trial Overview of Wake Forest University 55
University of Zurich 56
Clinical Trial Overview of University of Zurich 56
University of California, Irvine 57
Clinical Trial Overview of University of California, Irvine 57
Northwestern University 58
Clinical Trial Overview of Northwestern University 58
Hospital Universitario Reina Sofia 59
Clinical Trial Overview of Hospital Universitario Reina Sofia 59
Five Key Clinical Profiles 60
Appendix 113
Abbreviations 113
Definitions 113
Research Methodology 114
Secondary Research 114
About GlobalData 115
Contact Us 115
Disclaimer 115
Source 115

List of Tables

Moderate Psoriasis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Moderate Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Moderate Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Moderate Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Moderate Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Moderate Psoriasis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Moderate Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Moderate Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Moderate Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Moderate Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Moderate Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Moderate Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Moderate Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Moderate Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Moderate Psoriasis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Moderate Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Moderate Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Moderate Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Moderate Psoriasis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Moderate Psoriasis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Moderate Psoriasis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Moderate Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Moderate Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Moderate Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Moderate Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Moderate Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 34
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 37
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 39
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 41
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 43
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 45
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 46
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2014* 47
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014* 48
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 49
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2014* 50
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts Medical Center, 2014* 51
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014* 52
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 53
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 54
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 55
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 56
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2014* 57
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 58
Moderate Psoriasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Reina Sofia, 2014* 59

List of Figures

Moderate Psoriasis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Moderate Psoriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Moderate Psoriasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Moderate Psoriasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Moderate Psoriasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Moderate Psoriasis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Moderate Psoriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Moderate Psoriasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Moderate Psoriasis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Moderate Psoriasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Moderate Psoriasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Moderate Psoriasis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Moderate Psoriasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Moderate Psoriasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Moderate Psoriasis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Moderate Psoriasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Moderate Psoriasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Moderate Psoriasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Moderate Psoriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Moderate Psoriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Moderate Psoriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Moderate Psoriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Moderate Psoriasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 114

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.